Skip to main content

Articles

Page 8 of 11

  1. Vascular access (VA) intervention therapy (VAIVT) has been increasingly used for treating VA failure (VAF) in patients undergoing hemodialysis; however, clinical evidence demonstrating the efficacy of preventi...

    Authors: Tomohito Mizuno, Motonobu Nakamura, Nobuhiko Satoh, Hiroyuki Tsukada, Akihiko Matsumoto, Yoshifumi Hamasaki, Haruki Kume and Masaomi Nangaku
    Citation: Renal Replacement Therapy 2018 4:43
  2. Intradialytic plasma volume change (IPVC) owing to ultrafiltration is a dominant cause of intradialytic hypotension (IDH). Lower occurrence of IDH in hemodiafiltration (HDF) than in standard hemodialysis (std-...

    Authors: Masayuki Tanemoto, Yu Ishimoto, Yukio Kosako and Yukio Okazaki
    Citation: Renal Replacement Therapy 2018 4:42
  3. A newspaper article in August 2016 reported that about 40 medical facilities refused dialysis to a human immunodeficiency virus (HIV) patient. Infection Survey Subcommittee in the Japanese Society for Dialysis...

    Authors: Ayumi Yoshifuji, Munekazu Ryuzaki, Yasuhiko Ito, Norio Ohmagari, Yoshihiko Kanno, Toshio Shinoda, Yaoko Takano, Isao Tsukamoto, Kazuhiko Hora, Yasushi Nakazawa, Naoki Hasegawa, Tadashi Yoshida, Shu Wakino, Yoshiaki Takemoto and Hidetomo Nakamoto
    Citation: Renal Replacement Therapy 2018 4:41
  4. Pleuroperitoneal leak is an uncommon but significant complication of peritoneal dialysis. Although the exact pathogenesis of pleuroperitoneal communication remains unclear, the pressure gradient between the th...

    Authors: Yoshihiko Fujino, Noritaka Kawada, Katsukiyo Ito, Hiroshi Katsura, Hajime Maeda, Kensuke Mitsumoto and Takashi Uzu
    Citation: Renal Replacement Therapy 2018 4:40
  5. High-dose methotrexate (HD-MTX) therapy has been used to treat a wide range of oncological malignancies. While the therapy can be tolerated with hydration, urine pH control, and leucovorin rescue therapy, HD-M...

    Authors: Mineaki Kitamura, Satoko Kitamura, Machiko Fujioka, Rena Kamijo, Shinya Sato, Yasushi Sawayama, Tadashi Uramatsu, Yoko Obata, Yasushi Mochizuki, Masaharu Nishikido, Hideki Sakai, Yasushi Miyazaki, Hiroshi Mukae and Tomoya Nishino
    Citation: Renal Replacement Therapy 2018 4:39
  6. Hypereosinophilic syndrome (HES) consists of a group of disorders characterized by abnormal accumulation of eosinophils in the blood or peripheral tissues, independent of known secondary causes of eosinophilia...

    Authors: Eri Amano, Taro Horino, Osamu Ichii, Satoshi Inotani, Tatsuki Matsumoto, Kazu Hamada-Ode, Yoshiko Shimamura, Kosuke Inoue and Yoshio Terada
    Citation: Renal Replacement Therapy 2018 4:38
  7. The definition and guideline of sepsis and septic shock were recently updated. The aim of this study is to evaluate the ability of Third Consensus Definitions of Sepsis and Septic Shock (Sepsis-3) to predict o...

    Authors: Maho Akiu, Tae Yamamoto, Mariko Miyazaki, Kimio Watanabe, Emi Fujikura, Masaaki Nakayama, Hiroshi Sato and Sadayoshi Ito
    Citation: Renal Replacement Therapy 2018 4:37
  8. Refeeding syndrome is a potentially fatal electrolyte shift in patients with rapid feeding after low-calorie intake. Although the key to diagnosing refeeding syndrome is hypophosphatemia after feeding, renal d...

    Authors: Yoshihisa Miyamoto, Yoshifumi Hamasaki, Akihiko Matsumoto, Kent Doi and Masaomi Nangaku
    Citation: Renal Replacement Therapy 2018 4:35
  9. Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early d...

    Authors: Kent Doi, Osamu Nishida, Takashi Shigematsu, Tomohito Sadahiro, Noritomo Itami, Kunitoshi Iseki, Yukio Yuzawa, Hirokazu Okada, Daisuke Koya, Hideyasu Kiyomoto, Yugo Shibagaki, Kenichi Matsuda, Akihiko Kato, Terumasa Hayashi, Tomonari Ogawa, Tatsuo Tsukamoto…
    Citation: Renal Replacement Therapy 2018 4:36
  10. Decreased physical activity in hemodialysis (HD) patients causes various structural, metabolic, and functional abnormalities due to uremic changes in skeletal muscles. Electrical stimulation (ES) of the lower ...

    Authors: Misa Miura, Aki Hirayama, Shigeru Oowada, Akihito Nishida, Chie Saito, Kunihiro Yamagata, Osamu Ito, Yo Hirayama and Masahiro Kohzuki
    Citation: Renal Replacement Therapy 2018 4:33
  11. Polymethyl methacrylate (PMMA) membranes have the unique property of adsorption, which can remove medium- and large-weight molecular substances that cannot be removed by normal hemodialysis and hemodiafiltrati...

    Authors: Nobuko Uchiumi, Koji Sakuma, Sumihiko Sato, Yoshinaga Matsumoto, Hirotada Kobayashi, Koki Toriyabe, Katsumi Hayashi, Tadayuki Kawasaki, Takashi Watanabe, Ayumi Itohisa, Masanori Yokota, Katsumi Okazawa and Noriyoshi Murotani
    Citation: Renal Replacement Therapy 2018 4:32
  12. Historically, cellulose-based materials have been used for manufacturing hemodialysis membranes and remain to date as the commonly used materials. Though cellulose triacetate (CTA) membrane originally has a ho...

    Authors: Konomi Togo, Masahito Yamamoto, Motoyuki Imai, Keiichi Akiyama and Akihiro C. Yamashita
    Citation: Renal Replacement Therapy 2018 4:29
  13. Serum albumin is a marker of nourishment and inflammation. Although hypoalbuminemia in hemodialysis patients is reported as a risk factor for poor prognosis, few studies describe its effects on infectious dise...

    Authors: Shun Minatoguchi, Atsushi Nomura, Takahiro Imaizumi, Sho Sasaki, Takaya Ozeki, Daisuke Uchida, Hiroo Kawarazaki, Fumihiko Sasai, Keigo Tomita, Hideaki Shimizu and Yoshiro Fujita
    Citation: Renal Replacement Therapy 2018 4:30
  14. We investigated whether serum uric acid (SUA) levels before kidney transplantation predict new-onset diabetes after kidney transplantation (NODAT) and compared SUA levels with known risk factors for NODAT by p...

    Authors: Kentaro Tanaka, Ken Sakai, Akifumi Kushiyama, Shigeko Hara, Masakazu Hattori, Yasushi Ohashi, Masaki Muramatsu, Takeshi Kawamura, Seiichiro Shishido and Atsushi Aikawa
    Citation: Renal Replacement Therapy 2018 4:28
  15. Peripheral arterial disease (PAD) has much impact on mortality in hemodialysis (HD) patients. Ankle-brachial index (ABI) and skin perfusion pressure (SPP) are useful tools to detect PAD in HD patients. However...

    Authors: Kunihiro Ishioka, Takayasu Ohtake, Hidekazu Moriya, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Sumi Hidaka and Shuzo Kobayashi
    Citation: Renal Replacement Therapy 2018 4:27
  16. Pruritus in patients undergoing hemodialysis reduces quality of life via insomnia and depression, and negatively affects prognosis. For diagnosing pruritus, selecting therapeutic strategies, and determining th...

    Authors: Naoko Takahashi, Taku Yoshizawa, Aiko Okubo, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi, Takao Masaki and Toshiya Ebata
    Citation: Renal Replacement Therapy 2018 4:26
  17. Tuberous sclerosis complex is an autosomal dominant genetic disorder that affects multiple organ systems and can result in tumors in the brain, skin, heart, and kidneys; it may also cause neurological symptoms...

    Authors: Akira Ashida, Hideki Matsumura, Yuko Fujii, Hyogo Nakakura, Akihiko Shirasu and Hiroshi Tamai
    Citation: Renal Replacement Therapy 2018 4:25
  18. Low tongue pressure contributes to oral frailty. It is a condition in which the pressure between the tongue, palate, and food decreases due to a decrease in tongue muscle function. Low tongue pressure interfer...

    Authors: Yuka Kamijo, Eiichiro Kanda, Keisuke Ono, Keizo Maeda, Akane Yanai, Kazuya Honda, Ryuji Tsujimoto, Mai Yanagi, Yoshitaka Ishibashi and Masayuki Yoshida
    Citation: Renal Replacement Therapy 2018 4:23
  19. Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited disease among primary diseases in dialysis patients. Tolvaptan is known to improve increases in total kidney volume (TKV) in pa...

    Authors: Shuma Hirashio, Shigehiro Doi and Takao Masaki
    Citation: Renal Replacement Therapy 2018 4:24
  20. Infection is the second leading cause of mortality in patients who undergo maintenance hemodialysis. In this population, impairment in both cellular and humoral immunity contributes to the increased incidence ...

    Authors: Shunsuke Yamada, Narihito Tatsumoto, Noriko Nakamura, Kosuke Masutani, Toshiro Maeda, Takanari Kitazono and Kazuhiko Tsuruya
    Citation: Renal Replacement Therapy 2018 4:22
  21. Chronic kidney disease (CKD) is one of the main public health issues. It increases the morbidity and mortality of patients. Treatment includes multiple aspects such as dialysis and lifestyle modifications. The...

    Authors: Ibrahim Mousa, Raed Ataba, Khaled Al-ali, Abdulsalam Alkaiyat and Sa’ed H. Zyoud
    Citation: Renal Replacement Therapy 2018 4:21
  22. Hemodialysis catheters are commonly used for vascular access in patients undergoing blood purification therapies. However, the sudden dysfunction of catheters represents a serious problem, and while we know th...

    Authors: Yoshimitsu Takahashi, Junichiro J. Kazama, Suguru Yamamoto, Takashi Oite and Ichiei Narita
    Citation: Renal Replacement Therapy 2018 4:20
  23. Patients with end-stage renal failure may exhibit sarcopenia and protein-energy wasting (PEW). We report a case of improvement in physical function, muscle mass, and muscle strength by management of rehabilita...

    Authors: Chiharu Uno, Hidetaka Wakabayashi, Keisuke Maeda and Shinta Nishioka
    Citation: Renal Replacement Therapy 2018 4:18
  24. Asymptomatic peripheral artery disease (PAD) increases the risk of mortality in non-hemodialysis patients. However, the association between asymptomatic PAD and mortality rate remains unclear in patients on he...

    Authors: Manae Harada, Ryota Matsuzawa, Naoyoshi Aoyama, Kaoru Uemura, Yoriko Horiguchi, Junko Yoneyama, Keika Hoshi, Kei Yoneki, Takaaki Watanabe, Takahiro Shimoda, Yasuo Takeuchi, Shokichi Naito, Atsushi Yoshida and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2018 4:17
  25. l-carnitine is essential for lipid metabolism, and lack of l-carnitine intake and loss by treatments lead to carnitine depletion causing muscle weakness, anemia, and immune dysfunction. Carnitine depletion occurs...

    Authors: Takehiko Oami, Taku Oshima, Noriyuki Hattori, Ayako Teratani, Saori Honda, Toshihiko Yoshida and Shigeto Oda
    Citation: Renal Replacement Therapy 2018 4:13
  26. TAFRO (thrombocytopenia, anasarca, fever, reticulin myelofibrosis/renal failure, and organomegaly) syndrome is a systemic inflammatory disorder and unique clinicopathological variant of idiopathic multicentric...

    Authors: Arata Hibi, Ken Mizuguchi, Akiko Yoneyama, Takahisa Kasugai, Keisuke Kamiya, Keisuke Kamiya, Chiharu Ito, Satoru Kominato, Toshiyuki Miura and Katsushi Koyama
    Citation: Renal Replacement Therapy 2018 4:16
  27. The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities (98.7%) responded. The response ...

    Authors: Ikuto Masakane, Masatomo Taniguchi, Shigeru Nakai, Kenji Tsuchida, Shunsuke Goto, Atsushi Wada, Satoshi Ogata, Takeshi Hasegawa, Takayuki Hamano, Norio Hanafusa, Junichi Hoshino, Jun Minakuchi and Hidetomo Nakamoto
    Citation: Renal Replacement Therapy 2018 4:19
  28. All forms of shock, particularly septic shock, that involve insufficient blood supply to tissues to meet metabolic demands are main causes of morbidity and mortality worldwide and develop in one third of patie...

    Authors: Alexa Hollinger, Lukas Gantner, Franziska Jockers, Thomas Schweingruber, Katrin Ledergerber, Jonas Dominic Scheuzger, Markus Aschwanden, Michael Dickenmann, Johann Knotzer, Jasper van Bommel and Martin Siegemund
    Citation: Renal Replacement Therapy 2018 4:14
  29. The necessity of purification of dialysis fluids has been discussed since the 1980s. The Japanese Society for Dialysis Therapy (JSDT) presented a standard for dialysis fluid purification in 1995 and revised th...

    Authors: Michio Mineshima, Hideki Kawanishi, Tomonobu Ase, Tadayuki Kawasaki, Tadashi Tomo and Hidetomo Nakamoto
    Citation: Renal Replacement Therapy 2018 4:15
  30. Chronic kidney disease is a major risk factor for dementia, but the influence of hemodialysis itself on the development of dementia remains unclear. We previously reported that non-diabetic patients on mainten...

    Authors: Shigeru Nakai, Kenji Wakai, Eiichiro Kanda, Kazunori Kawaguchi, Kazuyoshi Sakai and Nobuya Kitaguchi
    Citation: Renal Replacement Therapy 2018 4:12
  31. This study aimed to explore the role of patient’s characteristic and haematological factors as predictive on the maturation of arteriovenous fistulae in patients who underwent vascular access surgery at the Ro...

    Authors: Muhammad A. Siddiqui, Suhel Ashraff, Derek Santos, Robert Rush, Thomas E. Carline and Zahid Raza
    Citation: Renal Replacement Therapy 2018 4:11
  32. In Japan, the most commonly used hemofilters for patients with acute kidney injury (AKI) treated with continuous renal replacement therapy (CRRT) are made of polysulfone membranes. The aim of this study was to...

    Authors: Hideto Yasuda, Kosuke Sekine, Takayuki Abe, Shinichiro Suzaki, Atsushi Katsumi, Naoshige Harada, Hidenori Higashi, Yuki Kishihara, Hidetaka Suzuki and Toru Takebayashi
    Citation: Renal Replacement Therapy 2018 4:6
  33. In the patients with severe atherosclerotic renal artery stenosis (ARAS), the evaluation of long-term clinical outcome after percutaneous transluminal renal angioplasty (PTRA) has yet been insufficient. The ai...

    Authors: Yasuhiro Mochida, Takayasu Ohtake, Yusuke Miyashita, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Hidekazu Moriya, Sumi Hidaka, Shigeru Saito and Shuzo Kobayashi
    Citation: Renal Replacement Therapy 2018 4:5
  34. To cope with the increasing number of patients on long-term hemodialysis (HD), especially those with diabetic nephropathy, we designed a fully automated HD system to decrease staff workload and hence human err...

    Authors: Takashi Shigematsu, Jun Minakuchi, Satoshi Funakoshi, Junichiro Hashiguchi, Hiroshi Yoshimoto, Kyoko Ito, Takuya Ban and Tetsunosuke Kunitomo
    Citation: Renal Replacement Therapy 2018 4:9
  35. Patients undergoing hemodialysis (HD) have difficulty performing activities of daily living (ADL) compared to healthy people. ADL difficulty is an early predictor of loss of independence and mortality in older...

    Authors: Takaaki Watanabe, Toshiki Kutsuna, Kei Yoneki, Manae Harada, Takahiro Shimoda, Yusuke Matsunaga, Norio Murayama, Ryota Matsuzawa, Yasuo Takeuchi, Atsushi Yoshida and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2018 4:8
  36. Peritoneal dialysis (PD)-related infection encompasses PD-related peritonitis and catheter-related infections, and the latter is used as the collective term to describe exit site infection (ESI) and tunnel inf...

    Authors: Cheuk Chun Szeto
    Citation: Renal Replacement Therapy 2018 4:7
  37. The management of renal anemia in the pre-dialysis period has been remarkably improved by long-acting erythropoiesis-stimulating agents (ESA). However, many incident dialysis patients cannot achieve target hem...

    Authors: Shinya Kawamoto, Yu Kaneko, Hideo Misawa, Katsuhiro Nagahori, Atsushi Kitazawa, Atsunori Yoshino and Tetsuro Takeda
    Citation: Renal Replacement Therapy 2018 4:4
  38. Chronic kidney disease (CKD) is an important global health challenge with increasing burden worldwide. CKD and acute kidney injury (AKI) may require renal replacement therapy (RRT) at some stages of the diseas...

    Authors: E. K. Tannor, Y. A. Awuku, V. Boima and S. Antwi
    Citation: Renal Replacement Therapy 2018 4:3
  39. Purple color of urine is alarming and may indicate a serious underlying pathology. Purple discoloration of the urinary catheter bag is uncommon and is caused by urinary tract infection with certain organisms.

    Authors: Ankit Kayal, Shashanka Dhanuka, Bibhas Chandra Mukhopadhyay, Tapan Kumar Mandal and Charu Lata Bansal
    Citation: Renal Replacement Therapy 2017 3:52
  40. Nutritional therapy and exercise training (ET) are important interventions for hemodialysis patients. We investigated the status of nutritional therapy and ET provided at hemodialysis facilities across Japan.

    Authors: Satoko Sakurai, Norio Hanafusa, Hideki Kato, Shinji Iizaka, Ryoko Murayama and Masaomi Nangaku
    Citation: Renal Replacement Therapy 2017 3:60
  41. In the present report case, we show a peritonitis infection in a continuous ambulatory peritoneal dialysis (CAPD) patient in Colombia. We isolated Rhodococcus equi in the peritoneal fluid culture. Rhodococcus equ...

    Authors: José Lucas Daza, Yaroslad De La Cruz, Jesús Morales, Carolina Molina, Mauricio Duque, Ingrid Prieto and Victoria Ballen
    Citation: Renal Replacement Therapy 2017 3:59
  42. Intradialytic hypotension (IDH) is a common clinical manifestation associated with poor prognosis in hemodialysis (HD) patients. HD patients who suffer from diabetic nephropathy (DN) are increasing and diabete...

    Authors: Kenji Tsuchida, Hirofumi Hashimoto, Kazuhiko Kawahara, Ikuro Hayashi, Yoshio Fukata, Munenori Kashiwagi, Akihiro C. Yamashita, Michio Mineshima, Tadashi Tomo, Ikuto Masakane, Yoshiaki Takemoto, Hideki Kawanishi, Kojiro Nagai and Jun Minakuchi
    Citation: Renal Replacement Therapy 2017 3:58
  43. Carnitine is reported to improve insulin resistance and reduce oxidative stress. Hyperglycemia and increased oxidative stress are well known to promote the production of advanced glycation end products (AGEs) ...

    Authors: Yumi Kamada, Takashi Masuda, Kazuhiko Kotani, Shinya Tanaka, Takeshi Nakamura, Nobuaki Hamazaki, Yoko Itoh, Ibuki Moriguchi, Naoyuki Kobayashi, Michihito Okubo, Kazuhiro Takeuchi, Shokichi Naito and Yasuo Takeuchi
    Citation: Renal Replacement Therapy 2017 3:57
  44. The reported prevalence rate of depressive symptoms in hemodialysis patients is 40%. Although appropriate management of these symptoms is important, they remain under-recognized and under-treated in hemodialys...

    Authors: Takahiro Shimoda, Ryota Matsuzawa, Keika Hoshi, Kei Yoneki, Manae Harada, Takaaki Watanabe and Atsuhiko Matsunaga
    Citation: Renal Replacement Therapy 2017 3:56
  45. Nalfurafine hydrochloride (“nalfurafine”), the world’s first selective oral κ-receptor agonist for improving pruritus, is approved in Japan for the treatment of pruritus resistant to existing treatments in hem...

    Authors: Hidetomo Nakamoto, Takanori Oh, Masahiro Shimamura, Eiji Iida and Sadanobu Moritake
    Citation: Renal Replacement Therapy 2017 3:51

Annual Journal Metrics

  • 2022 Citation Impact
    1.2 - 2-year Impact Factor
    0.703 - SNIP (Source Normalized Impact per Paper)
    0.438 - SJR (SCImago Journal Rank)

    2023 Speed
    12 days submission to first editorial decision for all manuscripts (Median)
    137 days submission to accept (Median)

    2023 Usage 
    545,038 downloads
    139 Altmetric mentions